| Han, zhengxiang |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
TQB2450-AL2846-III-01, NCT05922345: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. |
|
|
| Recruiting | 3 | 518 | RoW | TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules, TQB2450 placebo, docetaxel injection, AL2846 matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non-small Cell Lung Cancer | 08/25 | 12/25 | | |
FOCUS-C, NCT05334277: Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA |
|
|
| Recruiting | 2 | 280 | RoW | Furmonertinib, AST2818, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab | Sun Yat-sen University, Allist Pharmaceuticals, Inc., GeneCast Biotechnology Co., Ltd. | Non-small Cell Lung Cancer | 02/25 | 02/28 | | |
NCT06088472: TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors |
|
|
| Completed | 1 | 19 | RoW | TIL injection | Grit Biotechnology | Solid Tumors, Adult | 04/24 | 04/24 | | |
NCT05860374: A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors |
|
|
| Recruiting | 1 | 20 | RoW | Recombinant oncolytic herpes simplex virus type 1 (R130), Oncolytic virus | Shanghai Yunying Medical Technology, The Affiliated Hospital of Xuzhou Medical University | Sarcoma, Carcinoma, Breast Cancer, Pancreatic Cancer, Colorectal Cancer, Gastric Cancer, Liver Cancer, Lung Cancer, Gynecologic Cancer | 03/25 | 03/26 | | |
NCT05729399: Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors |
|
|
| Recruiting | 1 | 26 | RoW | GT201 | Grit Biotechnology | Solid Tumor | 05/25 | 05/25 | | |
